Oregovomab With or Without Cyclophosphamide in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Responded to Second-Line Chemotherapy

Name: Oregovomab With or Without Cyclophosphamide in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Responded to Second-Line Chemotherapy
License: Public Domain

Gynecologic Oncology Group

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

fallopian tube carcinoma, primary peritoneal carcinoma, recurrent ovarian carcinoma, stage iii ovarian cancer, stage iv ovarian cancer

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 201610
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.